Clinical Trials on Fosterv%C3%A6gt

Total 380 results

GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

Measles | Rubella | Mumps | Varicella

United States
Odense University Hospital

Completed

Treatment of Chronic Postherpetic Pain With Fat Grafting

Herpes Zoster | Post Herpetic Neuralgia

Denmark
GlaxoSmithKline

Completed

Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds

Measles | Rubella | Mumps | Varicella

Taiwan, Singapore
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children

Measles | Rubella | Mumps | Varicella

Italy
ContraVir Pharmaceuticals, Inc.

Terminated

A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia

Herpes Zoster | Postherpetic Neuralgia | Shingles

United States
Merck Sharp & Dohme LLC

Completed

Safety Study of ProQuad® rHA in Infants (V221-037)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

Safety Study of a Refrigerator-stable Formulation of VARIVAX®

Measles | Rubella | Mumps | Varicella

France, Italy
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)

Measles | Rubella | Mumps | Varicella
GlaxoSmithKline

Completed

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

Measles | Rubella | Mumps | Varicella

Germany
Merck Sharp & Dohme LLC

Completed

Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)

Varicella
Merck Sharp & Dohme LLC

Completed

Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)

Varicella

Russian Federation
Merck Sharp & Dohme LLC

Completed

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

Varicella

United States
Merck Sharp & Dohme LLC

Completed

Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)

Varicella
Dominik Irnich

Completed

Acupuncture in Herpes Zoster Neuralgia (ACUZoster) (ACUZoster)

Pain | Herpes Zoster | Postherpetic Neuralgia

Germany
University of Oklahoma
Oklahoma Medical Research Foundation

Completed

Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents (NH-Shingrix)

Herpes Zoster | Corona Virus Infection | Allergy and Immunology

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Safety and Tolerability | Compare SHINGRIX Vaccine Response Rates

United States
Vietnam Military Medical University
Vabiotech

Completed

Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old

Chickenpox

Vietnam
aRigen Pharmaceuticals, Inc.

Unknown

Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)

Herpes Zoster | Postherpetic Neuralgia

United States
Radboud University Medical Center
GlaxoSmithKline

Completed

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)

Influenza | Herpes Zoster

Netherlands
University of Witwatersrand, South Africa

Unknown

Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine (MV/VV/Hep-AV)

Measles | Hepatitis A | Varicella

South Africa
National Institute of Allergy and Infectious Diseases...

Terminated

Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines

Measles | Rubella | Mumps | Varicella

United States
AstraZeneca

Completed

Varicella Vaccination With Pulmicort

Asthma
Green Cross Corporation

Completed

Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults

Varicella (Chicken Pox)
University of California, San Francisco
Pfizer

Terminated

Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo

Herpes Zoster | Postherpetic Neuralgia

United States
Astellas Pharma Europe Ltd.

Completed

Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food

Herpes Zoster | Herpes Genitalis

France
GlaxoSmithKline

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Measles | Rubella | Mumps | Varicella

Germany, Italy, France
University of Wisconsin, Madison
Boston Medical Center

Active, not recruiting

Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis | Herpes Zoster

United States
GlaxoSmithKline

Completed

A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above

Herpes Zoster

Japan
Second Affiliated Hospital, School of Medicine,...

Unknown

Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia

Herpes Zoster | Post-herpetic Neuralgia
National Institute of Dental and Craniofacial Research...

Completed

Dextromethorphan Versus Placebo for Neuropathic Pain

Diabetic Neuropathies | Neuralgia | Herpes Zoster

United States
Huazhong University of Science and Technology

Not yet recruiting

Risk Factors of Anxiety and Depression in Patients With Herpes Zoster Neuralgia

Herpes Zoster
GlaxoSmithKline

Completed

Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in France

Herpes Zoster
Roxane Laboratories

Completed

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions

Herpes Zoster | Genital Herpes | Shingles

United States
GlaxoSmithKline

Completed

Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain

Herpes Zoster

Spain
Alnylam Pharmaceuticals

Completed

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria | PH1 | RNAi Therapeutic | siRNA | AGT

France, United Kingdom, Netherlands, Israel, Germany
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children

HIV Infections

United States
Charles Drew University of Medicine and Science

Not yet recruiting

ACTIVATE in Public Housing

COVID-19 | Pneumonia | Influenza | Meningitis | Vaccine Hesitancy | Varicella Zoster
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)

Measles | Rubella | Mumps | Varicella
GlaxoSmithKline

Completed

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Measles | Rubella | Mumps | Varicella

India
GlaxoSmithKline

Completed

Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

Measles | Rubella | Mumps | Varicella

Korea, Republic of
Roxane Laboratories

Completed

Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions

Herpes Zoster | Genital Herpes | Shingles

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Measles | Rubella | Mumps | Varicella

Belgium, Germany, Netherlands
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Measles | Rubella | Mumps | Varicella

Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Measles | Rubella | Mumps | Varicella

Finland, Germany, Poland, Greece
GlaxoSmithKline

Completed

Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

Measles | Rubella | Mumps | Varicella

Germany, Austria
Asan Medical Center

Completed

Prospective Observation of the Fluoroscopy-guided Cervical Epidural Approach Using the Contralateral Oblique View

Herpes Zoster | Cervical Radicular Pain | Postherpetic Neuralgia | Cervical Spinal Stenosis | Cervical Intervertebral Disc Disease

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

Measles | Rubella | Mumps | Varicella
GlaxoSmithKline

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Measles | Rubella | Mumps | Varicella

Canada, Italy
GlaxoSmithKline

Withdrawn

Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

Measles | Rubella | Mumps | Varicella

3

Subscribe